Peripheral Arterial Disease (PAD) Therapeutics Market Analysis Spreads In 108 Pages with 149 Figures and Tables – Sector : Medical Care
[108 Pages Report with Detailed Analysis] Peripheral Arterial Disease (PAD) Therapeutics Market (Description) : Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at USD 3109.7 million in the year 2022, is projected to reach a revised size of USD 4249.9 million by 2028, growing at a CAGR of 5.3% during the forecast period 2022-2028.
The USA market for Peripheral Arterial Disease (PAD) Therapeutics is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Peripheral Arterial Disease (PAD) Therapeutics is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Peripheral Arterial Disease (PAD) Therapeutics is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Peripheral Arterial Disease (PAD) Therapeutics include AstraZeneca Plc. (UK), Bayer HealthCare Pharmaceuticals (Germany), Bristol-Myers Squibb Company (US), Merck & Co., Inc. (US), Proteon Therapeutics, Inc. (US), Sanofi S.A. (France), Symic Bio, Inc. (US), TheraVasc Inc. (US) and AnGes MG, Inc. (Japan), etc. In 2021, the global top five players had a share approximately % in terms of revenue.
SEGMENTATION ANALYSIS
Top Key players:
By Types
By Application
Get a Sample PDF of report – https://www.360researchreports.com/enquiry/request-sample/21992727
Emergency Beacon Transmitter Market
Super Duplex Stainless Steel Market
Engineered Parquet Flooring Market
Noise Vibration Harshness (Nvh) Testing Market
Cadcam Milling Machine For Dental Laboratory Market
Zirconate Titanate Ceramic Market
Remotely Operated Vehicle (ROV) Market
Infrared Search and Track (IRST) System Market
Potassium Cocoyl Glycinate and Sodium Cocoyl Glycinate Market
Desiccants And Adsorbents Market
Gaming Headsets & Gaming Headphones Market
3D Gesture Sensing Control Market
Flexible and Semi-rigid Ureteroscopy Market
